Zdrowie i gospodarka · 08/07/2026
Government Owned Invention Available for License: Method of Detecting Circulating Cell-Free HPV 6 and 11 DNA in Patients Afflicted With Diseases Caused by Chronic HPV 6 or 11 Infection and Use Thereof
The National Cancer Institute (NCI) and Frederick National Laboratory for Cancer Research (FNLCR) are seeking partners to co-develop and license a novel liquid biopsy diagnostic for non-invasive detection of cell-free HPV 6 and 11 DNA in patients with recurrent respiratory papillomatosis (RRP).